CClinicalTrials.gg
Sign In
RecruitingNCT06120010Updated Nov 7, 2023

Prevalence of Anatomical Variants of Dural Sinuses by MRV Evaluation in Sohag

An observational study in Anatomical Variants of Dural Sinuses by MRV, sponsored by Sohag University. Recruiting at 1 site in Egypt. Open to female participants. Per ClinicalTrials.gov, last updated 2023-11-07.

Sponsored by Sohag University · Observational

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 3 months ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years later.
Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
169
Sex
Female
01

Study summary

The purpose of this study is to use the MRV to depict the prevalence of anatomical variants of dural venous sinuses in Sohag population, which can help to avoid potenital pitfalls in the diagnosis of dural venous sinus thrombosis, venous infarcts and venous hemorrhage.

02

Conditions studied

  • Anatomical Variants of Dural Sinuses by MRV
03

In context

Lead sponsor

Sohag University is the lead sponsor of 1,183 studies on the registry; 612 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Sampling method
Probability sample

Study population

Sohag by nationality and residence, male or female by sex, having normal cerebral MRV reported and consented to participate in the research work will be included in this research.

Inclusion criteria

  • Sohag by nationality and residence, male or female by sex, having normal cerebral MRV reported and consented to participate in the research work will be included in this research.

Exclusion criteria

Exclusion Criteria:

  • Having the diagnosis of cerebral venous sinus thrombosis, congential or acquired intracranial abnormalities, ischemic or hemorrhagic stroke, intracranial hypertension, intracranial space occuping lesion, and previous head injury or neurosurgery, also patients with absolute or relative contraindications for imaging including claustrophobia, metallic implants, pacemaker and prosthetic heart valves for MRI.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
169 participants (estimated)
Patient registry
No

Interventions

  • DeviceMRI

    To detect prevalence of anatomical variants of dural sinuses by MRV

06

What researchers measure

Primary outcomes

  1. Prevalence of anatomical variants of dural sinuses in Sohag population

    Number of anatomical variants of dural sinuses by MRV evaluation in Sohag

    Time frame: 8 months

07

Study locations

1 of 1 sites recruiting
  • Sohag university Hospital
    Sohag, Sohag, Egypt
    • Magdy M Amin, professor · Contact
    Recruiting
08

References and documents

Publications

  • van Dam LF, van Walderveen MAA, Kroft LJM, Kruyt ND, Wermer MJH, van Osch MJP, Huisman MV, Klok FA. Current imaging modalities for diagnosing cerebral vein thrombosis - A critical review. Thromb Res. 2020 May;189:132-139. doi: 10.1016/j.thromres.2020.03.011. Epub 2020 Mar 19. PubMed 32220779 ↗
  • Leach JL, Fortuna RB, Jones BV, Gaskill-Shipley MF. Imaging of cerebral venous thrombosis: current techniques, spectrum of findings, and diagnostic pitfalls. Radiographics. 2006 Oct;26 Suppl 1:S19-41; discussion S42-3. doi: 10.1148/rg.26si055174. PubMed 17050515 ↗
  • Cure JK, Van Tassel P, Smith MT. Normal and variant anatomy of the dural venous sinuses. Semin Ultrasound CT MR. 1994 Dec;15(6):499-519. doi: 10.1016/s0887-2171(05)80019-8. PubMed 7880564 ↗
  • Tubbs RS, Bosmia AN, Shoja MM, Loukas M, Cure JK, Cohen-Gadol AA. The oblique occipital sinus: a review of anatomy and imaging characteristics. Surg Radiol Anat. 2011 Nov;33(9):747-9. doi: 10.1007/s00276-011-0831-9. Epub 2011 May 29. PubMed 21626273 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 7, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06120010
Lead sponsor
Sohag University
Responsible party
Marina Makram Sabah (Resident-Diagnostic and interventional Radiology department, Sohag University) — Principal investigator
First posted
Nov 7, 2023
Start date
Sep 30, 2023
Primary completion
Jun 30, 2024 (estimated)
Completion
Jun 30, 2024 (estimated)
Last update
Nov 7, 2023

Study contacts

Marina M Sabah, resident
Contact
marinamakram@med.sohag.edu.eg
01201796003
Mohamed Th Mahmoud, professor
Contact

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Sohag University

Start the discussion